CIP2A and neoplasm: In contrast, detection of CIP2A or PME-1 overexpression in (type I) EC cannot rely on genetic methods, but should rather focus on the mRNA or protein level, and is therefore, much more dependent on the availability of tumor biopsies or resected tumor material.